Error type | Example | Total | Foundation Year 1 and 2 | All other prescribers | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Rank | Observed | Percentage | Rank | Observed | Percentage | Rank | Observed | Percentage | ||
Omission—indication | Indication not specified when prescribing Oramorph | 1 | 46 | 15.38% | 1 | 21 | 12.43% | 1 | 25 | 19.23% |
Brand name | Isosorbide mononitrate prescribed by the brand name Monomil XL rather than the generic name | 2 | 33 | 11.04% | 3 | 15 | 8.88% | 2 | 18 | 13.85% |
Wrong dose | Loperamide prescribed as number of tablets rather than actual dose | 3 | 32 | 10.70% | 2 | 18 | 10.65% | 3 | 14 | 10.77% |
Abbreviation | Dose written as ‘0.25 µg’ rather than ‘0.25 micrograms’ in prescription of alfacalcidol | 4 | 15 | 5.02% | 6 | 8 | 4.73% | 5 | 7 | 5.38% |
Wrong frequency | Latanoprost prescribed to be taken twice daily rather than once daily | 4 | 15 | 5.02% | 4 | 12 | 7.10% | 8 | 3 | 2.31% |
Omission—date | Date of prescription not specified when prescribing dalteparin | 6 | 13 | 4.35% | 8 | 7 | 4.14% | 6 | 6 | 4.62% |
Omission—course length | Course length not specified in prescription of Tazocin for patient with diabetic foot | 7 | 12 | 4.01% | 10 | 4 | 2.37% | 4 | 8 | 6.15% |
Wrong time | Meropenem prescribed intravenously for a haemodialysis patient in the morning rather than at night (after haemodialysis) | 8 | 11 | 3.68% | 5 | 11 | 6.51% | 11 | 0 | 0.00% |
Omission—frequency | Maximum daily frequency not specified when prescribing paracetamol | 9 | 9 | 3.01% | 6 | 8 | 4.73% | 10 | 1 | 0.77% |
Duplication | Duplication of prescribed therapy | 10 | 8 | 2.68% | 9 | 6 | 3.55% | 9 | 2 | 1.54% |
Omission—signature | Prescriber's signature is not legible or not written | 10 | 8 | 2.68% | 10 | 4 | 2.37% | 7 | 4 | 3.08% |